![Pamela Stephenson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pamela Stephenson
Corporate Officer/Principal presso
DISC MEDICINE, INC.
Patrimonio netto: 1 M $ in data 31/05/2026
Profilo
Pamela Stephenson is Chief Commercial Officer at Disc Medicine, Inc. since 2024.
Formerly, Ms. Stephenson was Chief Commercial Officer at Albireo Pharma, Inc. from 2019 to 2023, Independent Director at Harmony Biosciences Management, Inc. from 2019 to 2023, and Vice President-Global Market Access & Value at Vertex Pharmaceuticals, Inc. from 2008 to 2019.
Education includes undergraduate studies at Brown University and graduate studies at Boston University School of Public Health.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
DISC MEDICINE, INC. 0,05% | 22/04/2026 | 18.665 ( 0,05% ) | 1 M $ | 31/05/2026 |
Posizioni attive di Pamela Stephenson
| Società | Posizione | Inizio |
|---|---|---|
| DISC MEDICINE, INC. | Corporate Officer/Principal | 26/02/2024 |
Precedenti posizioni note di Pamela Stephenson
| Società | Posizione | Fine |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 10/10/2023 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 01/04/2023 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/03/2019 |
Formazione di Pamela Stephenson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
61
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Zynerba Pharmaceuticals, Inc.
 Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Public Health
 Boston University School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Disc Medicine, Inc.
 Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
